School of Medicine
Showing 41-50 of 72 Results
-
Kim-Son Nguyen
Adjunct Clinical Assistant Professor, Medicine - Oncology
BioDr. Kim-Son H. Nguyen obtained his Bachelor of Arts degree from Harvard College, with a concentration in genetics, his Doctor of Medicine from Harvard Medical School, and Master of Public Administration from the Harvard Kennedy School of Government before becoming a faculty member of Harvard Medical School. He then completed his fellowship in hematology and oncology at Stanford University School of Medicine and Stanford Cancer Institute. While maintaining an active clinical practice at Palo Alto Medical Foundation, Dr. Nguyen is an adjunct clinical assistant professor of medicine at Stanford University School of Medicine, with research interests including the molecular epidemiology of lung cancer, cancer screening, cancer therapeutics, and cancer care delivery.
With a unique training and extensive experience in cancer genetics, clinical research, and public policy, Dr. Nguyen has been involved in improving cancer care globally for many years. A former director of the American Society of Clinical Oncology International Program in Vietnam, he is passionate about bringing the latest oncology knowledge to cancer-treating health care providers in resource-limited settings, improving cancer care in disadvantaged patient populations, and promoting clinical research in developing countries. -
Linda Nguyen
Clinical Professor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsMy research interests focus on disorder of gastrointestinal motility. Specifically, those related to nausea and vomiting with or without gastroparesis, irritable bowel syndrome and chronic abdominal pain. My research focuses on understanding the cause of symptoms and development of new treatments targeting either symptom control and disease modification.
-
Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Professor of Medicine (Gastroenterology and Hepatology) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsWe conduct clinical trials and epidemiological, translational, and real-world studies of liver cancer, fatty liver (NASH, NAFLD), viral hepatitis B and C, liver cirrhosis, and liver transplant. We focus on risk identification for disease prevention and treatment for improvement of survival. We focus on sex, racial/ethnic, and socioeconomic disparities. We specialize in clinical trials, large international real-world consortium registry data, and large public/semi-public databases.
-
Minh Dai Nguyen
Postdoctoral Scholar, Gastroenterology
BioDr. Minh Nguyen joined the Prof. Jeffrey Glenn laboratory as a postdoctoral scholar in August 2022. In collaboration with Safaran ChEM-H Medicinal Chemistry Knowledge Center, his research objective is to harness the power of organic synthesis toward the development of novel antiviral therapies. Minh obtained his Ph.D. in Chemistry from the University of Pennsylvania under the direction of Prof. Amos B. Smith, III, where his doctoral work centered on the convergent total synthesis of two marine natural products nahuoic acids Cii and Dii.
-
Minh Nguyen
Ph.D. Student in Biomedical Informatics, admitted Autumn 2018
Ph.D. Minor, Management Science and EngineeringBio@DARE fellow (Diversifying Academia, Recruiting Excellence) https://vpge.stanford.edu/people/minh-nguyen
@Data Science Scholar
https://datascience.stanford.edu/people/minh-nguyen -
Quan Dong Nguyen, MD, MSc
Professor of Ophthalmology and, by courtesy, of Pediatrics and of Medicine (Immunology & Rheumatology)
Current Research and Scholarly InterestsWe have focused our research on the development of novel therapies and innovative assessment and diagnostic imaging technologies for retinal vascular and ocular inflammatory disorders, specifically diabetic retinopathy (DR), age-related macular degeneration (AMD) and uveitis. Building on our initial work describing the role of hypoxia and vascular endothelial growth factor (VEGF) in diabetic retinopathy (DR) and diabetic macular edema (DME), We have become interested in the biochemical mechanisms that would presumably lead to DME. During the past decade, our research has contributed to the body of evidences that defines the important role of anti-VEGF therapies in DME and AMD, as well as the role of the mTOR pathway and various interleukins in the pathogenesis of uveitis.
We have launched a productive and well-funded clinical research program while at the same time providing clinical care to patients with uveitis and retinal vascular diseases and fulfilling significant teaching and administrative assignments. We have established a number of key collaborators both within and outside the institutions. In addition, we have also established Center in Baltimore and now in Silicon Valley, which has excelled in conducting proof-of concept, early-phase multi-center clinical trials and studies, exploring the clinical disease manifestations and the efficacy of various pharmacologic agents in retinal, uveitic, and ocular inflammatory disorders.
